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Abstract: Systemic antibiotics are routinely prescribed in implant procedures, but the lack of con-
sensus causes large differences between clinicians regarding antibiotic prophylaxis regimens. The
objectives of this systematic review are to assess the need to prescribe antibiotics to prevent early
implant failure and find the most appropriate antibiotic prophylaxis regimen. The electronic search
was conducted in PubMed/MEDLINE, Scielo and Cochrane Central Trials Database for randomized
clinical trials of at least 3 months of follow-up. Eleven studies were included in the qualitative
analysis. Antibiotics were found to statistically significantly reduce early implant failures (RR = 0.30,
95% CI: 0.19–0.47, p < 0.00001; heterogeneity I2 = 0%, p = 0.54). No differences were seen between
preoperative or both pre- and postoperative antibiotic regimens (RR = 0.57, 95% CI: 0.21–1.55, p = 0.27;
heterogeneity I2 = 0%, p = 0.37). A single preoperative antibiotic prophylaxis dose was found to be
enough to significantly reduce early implant failures compared to no antibiotic (RR = 0.34, 95% CI:
0.21–0.53, p < 0.00001; heterogeneity I2 = 0%, p = 0.61). In conclusion, in healthy patients a single
antibiotic prophylaxis dose is indicated to prevent early implant failure.
Keywords: antibiotics; systemic antibiotic prophylaxis; early implant failure; dental implants;
systematic review; meta-analysis
1. Introduction
The failure of dental implants according to chronological criteria can be divided into
early failure, when it occurs before or during the abutment connection, or late failure,
after prosthetic loading [1]. Early implant failure is due to the lack of osseointegration [1]
and occurs in approximately 2% of cases [2]. It has been linked to numerous factors
such as lack of primary stability, contamination of the implant surface during placement,
surgical trauma, excessive micromovements during the healing process, poor bone quality
or quantity, implants with reduced length or smoking among others [2–7].
Due to the diversity of the microbiota present in the oral cavity, the second most
diverse and large on the human body [8], systemic antibiotics are routinely prescribed to
prevent infection and the consequent early implant failure [9,10]. However, there is no
standardized protocol regarding antibiotic prescription and cross-sectional studies have
revealed large differences in the type of antibiotic, dosage, time of administration and
duration of the treatment [9,10]. Furthermore, the scientific evidence is not solid on the
need for systemic antibiotics in oral implantology [11,12] and it must be considered the
possible adverse effects related to these drugs [13] and the continuous increase of antibiotic
resistance [14].
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Randomized clinical trials (RCTs) on this topic show different conclusions: that an-
tibiotic prescription may not be necessary in case of proper asepsis [12] or in single im-
plants [11], that it is justified since it reduces early implant failure and results in a better
postoperative period [15], or that significantly reduces early implant failure [16].
Regarding the type of administration, most of the studies suggest that a single pre-
operative dose of antibiotic is enough to prevent the early implant failure, thus avoiding
long-term antibiotic administration [16–19]. Even so, clinicians tend to prescribe long dura-
tion antibiotic regimens, pre- and postoperative administration are the most common [10].
The type of antibiotic is the only aspect in which there seems to be a consensus,
amoxicillin being the most widely prescribed antibiotic in implant dentistry followed by
amoxicillin in association with clavulanic acid [9,10]. Likewise, clindamycin is the most
common alternative in patients allergic to penicillin [9].
Due to this lack of consensus and with the aim of shedding light on this issue, the
objectives of this systematic review are to assess the need for systemic antibiotics in patients
undergoing dental implant placement to prevent early implant failures and to find the most
appropriate antibiotic prophylaxis regimen in these procedures considering its efficacy and
the prescribed dose.
2. Materials and Methods
The present systematic review and meta-analysis was performed in accordance with
the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) state-
ment [20]. A detailed protocol was prepared before starting the review and registered on
Prospero (CRD42021248348).
2.1. Focused Questions
Does the administration of antibiotic prophylaxis reduce early implant failure?
If the answer is yes, what is the best antibiotic prophylaxis regimen to reduce early
implant loss?
2.2. PICO Question
P (population): Partial or totally edentulous patients undergoing dental implant
surgery.
I (intervention): Administration of any type of systemic antibiotic, regardless of
dosage, duration or time of administration.
C (comparation): Different type of antibiotic, dosage, duration or time of administra-
tion, or compared to placebo or no antibiotic.
O (outcome): Early implant failure (dental implants that must be removed before
prosthetic loading because of mobility or infection).
2.3. Eligibility Criteria
Inclusion criteria:
• Randomized Clinical Trials.
• At least 3 months follow-up.
• Antibiotic prophylaxis regimen clearly described.
• Partial or totally edentulous patients undergoing dental implant surgery.
Exclusion criteria:
• Local antibiotic application instead of systemic antibiotic prophylaxis.
• Patients requiring antibiotic prophylaxis for medical reasons.
2.4. Search Strategy
An electronic search of the literature was conducted by two authors (E.R.-M. and
A.E.-D.) for articles written in English or Spanish published from January 2000 to April 2021.
The consulted databases were PubMed/MEDLINE, Scielo and Cochrane Central Trials
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Database. An additional hand search was performed to identify studies with potential of
inclusion in the references of the articles identified in the electronic search. Both searches
were conducted on 9 April 2021. The following term combination was used in all databases:
(“antibiotics [All Fields]” OR “anti-bacterial agents [All Fields]” OR “amoxicillin [All
Fields]”) AND (“dental implant [All Fields]” OR “implantology [All Fields]” OR “implant
placement [All Fields]” OR “implant failure [All Fields]”).
2.5. Study Selection
The study selection was carried out by two authors (E.R.-M. and A.E.-D.). After
discarding duplicate articles, the titles were read to identify studies with potential for
inclusion. Then, the abstracts were read to discard papers that did not meet the inclu-
sion/exclusion criteria. Full text of the selected articles was read to verify that they met
the inclusion/exclusion criteria. Disagreements between the two authors were solved
consulting a third author (J.L.-L.).
2.6. Data Extraction
The data were independently extracted by two authors (E.R.-M. and A.M.) and entered
in data collection forms (Microsoft Excel version 16.35). In case of disagreement a third
author was consulted (J.L.-L.). The collected data included author(s), year of publication,
country, type and number of centers, follow-up period, number of patients and implants
analyzed, inclusion and exclusion criteria, aseptic measures before and after surgery and
type of antibiotic, dosage, duration and time of administration of the different test and
control groups. Corresponding authors were contacted in the event that data were missing.
2.7. Risk of Bias in Included Studies
Version 2 of the Cochrane Collaboration’s tool for assessing risk of bias in randomized
clinical trials (RoB 2) [21] was implemented to assess the risk of bias of the RCT. The
evaluated domains were: randomization process, deviations from intended interventions,
missing outcome data, measurement of the outcome and selection of the reported result.
Studies were classified as: “low risk of bias”, “high risk of bias” or “some concerns”. Robvis
web app was used to create the risk of bias plots [22].
2.8. Data synthesis and Statistical Analysis
A qualitative analysis of the included articles was be carried out by grouping those
according to the characteristics of the test and control groups.
For the quantitative analysis, pooled estimates from the studies were performed
using a fixed or random effect-model depending on the heterogeneity (I2 ≥ 40%). Review
Manager (RevMan) (computer program, version 5.4, The Cochrane Collaboration, 2020)
was implemented to calculate the Risk Ratio (RR) and 95% confidence interval. The level
of significance was set at p < 0.05 and heterogeneity was evaluated with Chi2 and I2 tests.
The statistical unit was the dental implant.
3. Results
3.1. Study Selection
Through the electronic search, a total of 749 records were identified. After discarding
the duplicates, 710 titles and, if necessary the abstracts, were read to assess the potential for
inclusion. A total of 698 studies were excluded. The full text of the remaining 12 articles
and the two works identified through hand search were evaluated to verify they met
the inclusion/exclusion criteria [11,12,15–19,23–29]. One was discarded because it was
a quasi-random controlled clinical trial [25], a second one was excluded because the
assessed variable was not early implant failure [24] and another was ruled out because
the follow-up period was 8 weeks [23]. Finally, 11 studies were included in the qualitative
analysis [11,12,15–19,26–29] (Figure 1).
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diagram of the selection process.
3.2. Study Methods and Characteristics
All the included stu ies were RCT, published between 2008 and 2019 (Table 1). Five of
them were carried out in a single center (a total of 327 patients, minimum 46 and maximum
80, and 624 implants, minimum 46 and maximum 247) [12,15,17,18,29] and the other six
were multicenter (1817 patients, minimum 100 and maximum 506, and 3413 implants,
ini um 105 and maximum 972) [11,16,19,26–28]. Four took place in university centers
(247 pat ents, mini m 46 and maximum 80, a d 534 implants, minimum 46 and maxi um
247) [12,15,17,29] and the other seven in private practice clinics (1897 patients, minimum 80
and maximum 506, and 3503 implants, minimum 90 and maximum 972) [11,16,18,19,26–28].
The mean follow-up period was 4.5 months (range 3–10). The total number of patients and
implants analyzed were 2144 and 4037, respectively. The inclusion and exclusion criteria
of the included stu ies and the hygienic an asepsis easures pre- and post-surgery are
collected in Table .
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Table 1. Characteristics of the included studies.





Abu-Ta’a et al. 2008 [12] Belgium University Single 5 80 247
Esposito et al. 2008 [28] Italy Private practice Multicentric 4 316 696
Anitua et al. 2009 [11] Spain Private practice Multicentric 3 105 105
Esposito et al. 2010 [27] Italy Private practice Multicentric 4 506 972
Caiazzo et al. 2011 [26] Italy Private practice Multicentric 3 100 148
El-Kholey et al. 2014 [18] Saudi Arabia Private practice Single 3 80 90
Nolan et al. 2014 [15] Ireland University Single 4 55 55
Arduino et al. 2015 [19] Italy Private practice Multicentric 10 343 529
Moslemi et al. 2015 [29] Iran University Single 6 46 46
Andrade et al. 2017 [17] Brazil University Single 3 66 186
Kashani et al. 2019 [16] Sweden Private practice Multicentric 4 447 963
Five RCT compared antibiotic prophylaxis regimens with placebo administration
(1028 patients, minimum 46 and maximum 506, and 1874 implants, minimum 46 and
maximum 972) [11,15,27–29]. Another three compared antibiotic prophylaxis administra-
tion with no antibiotic (627 patients, minimum 80 and maximum 447, and 1358 implants,
minimum 148 and maximum 963) [12,16,26]. The last three compared different antibiotic
prophylaxis regimens without a placebo or no antibiotic group (489 patients, minimum 66
and maximum 343, and 805 implants, minimum 90 and maximum 529) [17–19]. The antibi-
otic used was in all cases amoxicillin, except in one study in which allergic to penicillin
patients were also included and were prescribed clindamycin [16].
Most studies had a preoperative antibiotic prophylaxis group (978 patients, minimum 25
and maximum 252, and 1853 implants, minimum 27 and maximum 535) [11,15–19,26–28], five
studies had a group with antibiotic administration pre- and post-surgery (313 patients, minimum
25 and maximum 177, and 595 implants, minimum 36 and maximum 128) [12,17–19,26] and
only two RCT had a group which only was prescribed postoperative antibiotic regimen
(48 patients, minimum 23 and maximum 25, and 72 implants, minimum 24 and maximum
48) [26,29] (Table 3). One RCT did not specify the number of implants per group [17].
In cases in which a single dose antibiotic prophylaxis was prescribed, the most frequent
dose was 2 g amoxicillin 1 h before the surgery. Although in one study 1 g amoxicillin
was administered [18] and in another 3 g amoxicillin [15]. In case of patients allergic to
penicillin, 600 mg clindamycin was administered 1 h before the implant placement [16].
In cases in which only postoperative antibiotic was administered, the duration of
the treatment was 7 days [26,29]. When pre- and postoperative antibiotic regimens were
prescribed, only two of the studies administered 7 days of antibiotic post-surgery [17,26],
the other three opted for short term antibiotic regimens (2–3 days) [12,18,19].
Regarding hygienic and aseptic measures, in five of the studies patients received
prophylaxis, debridement and/or oral hygiene instructions when required a few days
before implant surgery [11,26–29]. In most of the RCT, chlorhexidine mouthwash rinses
were performed before [11,15,17–19,26,27,29] or after the intervention [15,18,19,26–29].
Regarding the complexity, two studies specified that the surgical procedures in-
volved only the placement of simple single dental implants [11,29]. Data about the inclu-
sion/exclusion of immediate implants, implants with immediate loading and implants
with simultaneous bone grafting in the included studies are summarized in Table 2.
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Abu-Ta’a et al. 2008 [12] No No No Not uncon-trolled NA No Yes Yes NA NA NA NA NA NA
Esposito et al. 2008 [28] No No No No No(intravenous) No Yes NA Yes Yes No Yes NA Yes
Anitua et al. 2009 [11] No No No NA No <5000 rads Yes Yes NA Yes NA Yes Yes NA
Esposito et al. 2010 [27] No No No No No(intravenous) No Yes NA Yes Yes No Yes Yes Yes
Caiazzo et al. 2011 [26] No NA No NA No NA Yes Yes NA NA NA Yes Yes Yes
El-Kholey et al. 2014 [18] No No No No No NA Yes Yes No No No NA Yes Yes
Nolan et al. 2014 [15] No No No No NA No Yes No No No No NA Yes Yes
Arduino et al. 2015 [19] No No No No No No Yes Yes NA No No NA Yes Yes
Moslemi et al. 2015 [29] No No No No No No No No NA No No Yes Yes Yes
Andrade et al. 2017 [17] No No No No No No Yes Yes NA No NA NA Yes NA
Kashani et al. 2019 [16] Yes No No NA No No Yes Yes NA NA Yes NA NA NA
NA: not available; CHX: chlorhexidine.
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Preoperative Postoperative Pre and Post
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El-Kholey et al. 2014 [18] Amoxicillin 1 g 1 h pre Amoxicillin 1 g 1 h pre and 500 mg× 3 × 3 post
Nolan et al. 2014 [15] Amoxicillin 3 g 1 h pre - - Placebo
Arduino et al. 2015 [19] Amoxicillin 2 g 1 h pre Amoxicillin 2 g 1 h pre and 1 g × 2 ×3 post
Moslemi et al. 2015 [29] - Amoxicillin 500 mg × 3× 7 - Placebo
Andrade et al. 2017 [17] Amoxicillin 2 g 1 h pre Amoxicillin 2 g 1 h pre and 500 mg× 3 × 7 post
Kashani et al. 2019 [16] Amoxicillin 2 g orclindamycin 600 mg 1 h pre - - No antibiotics
3.3. Risk of Bias in Included Studies
Four of the included RCT obtained a low overall risk of bias [11,18,27,28] while in
the others there were some concerns regarding the overall risk [12,15–17,19,26,29]. The
domain with the highest risk of bias was the one referring to the deviations from intended
interventions. The domains in which a lower risk of bias was obtained were those that
refer to missing outcome data and measurement of the outcome (Figure 2).
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3.4. Early Implant Failure 
Of the eight studies that compared the administration of antibiotic 
prophylaxis with no antibiotic or with placebo [11,12,15,16,26–29], only 
one found statistically significant differences between groups [16]. That 
RCT compared the preoperative administration of amoxicillin 2 g or 
clindamycin 600 mg with no antibiotic. Even so, the rest of the studies 
found less early implant failures in the antibiotic groups 
[11,12,15,16,26–29]. 
Four RCT compared preoperative antibiotic regimen with both 
pre- and postoperative antibiotic regimen, and in none of the cases 
were statistically significant differences found [17–19,26]. Only one 
work compared a postoperative antibiotic regimen with preoperative 
and both pre- and postoperative regimens and observed no statistically 
significant differences [26]. 
The implant failure rate in the antibiotic groups was 1.55%, while 
in the no antibiotic or placebo groups was 4.61%. 
3.5. Meta-Analyses 
Different pooled estimates were performed using a fixed effect-
model because heterogeneity was I2 < 40%. The prescription of antibiotic 
prophylaxis, regardless of the dosage or the time of administration, 
proved to be a protective factor for early implant failure, with 
statistically significant results (RR = 0.30, 95% CI: 0.19–0.47, p < 0.00001; 
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3.4. Early Implant Failure
Of the eight studies that compared the administration of antibiotic prophylaxis with
no antibiotic or with placebo [11,12,15,16,26–29], only one found statistically significant
differences between groups [16]. That RCT compared the preoperative administration of
amoxicillin 2 g or clindamycin 600 mg with no antibiotic. Even so, the rest of the studies
found less early implant failures in the antibiotic groups [11,12,15,16,26–29].
Four RCT compared preoperative antibiotic regimen with both pre- and postopera-
tive antibiotic regimen, and in none of the cases were statistically significant differences
found [17–19,26]. Only one work compared a postoperative antibiotic regimen with preop-
erative and both pre- and postoperative regimens and observed no statistically significant
differences [26].
The implant failure rate in the antibiotic groups was 1.55%, while in the no antibiotic
or placebo groups was 4.61%.
3.5. Meta-Analyses
Different pooled estimates were performed using a fixed effect-model because hetero-
geneity was I2 < 40%. The prescription of antibiotic prophylaxis, regardless of the dosage
or the time of administration, proved to be a protective factor for early implant failure,
with statistically significant results (RR = 0.30, 95% CI: 0.19–0.47, p < 0.00001; heterogeneity
I2 = 0%, p = 0.54) [11,12,15,16,26–29] (Figure 3).
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The meta-analysis comparing preoperative antibiotics versus pre- and postoperative
antibiotics did not show differences between groups (RR = 0.57, 95% CI: 0.21–1.55, p = 0.27;
heterogeneity I2 = 0%, p = 0.37) [17–19,26]. It must be considered that in two of the three
studies included there was no implant failure in either of the two groups [18,26], so the
effect of the different antibiotic regimens in these two studies was not estimable. For this
reason, the result depended only on two studies [17,19] (Figure 4).
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A single preoperative antibiotic dose compared with no antibiotic prescription, turned
out to be a significant protective factor in early implant failure (RR = 0.34, 95% CI: 0.21–0.53,
p < 0.00001; heterogeneity I2 = 0%, p = 0.61) [11,15,16,26–28] (Figure 5).
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4. Discussion
According to the results obtained in the present systematic review and meta-analysis,
antibiotic prophylaxis is indicated in dental implant procedures since they statistically
significantly reduce early implant failure. No difference has been observed between the
administration of a single preoperative antibiotic dose a the combination of pre- and
posto erative antibioti s. A single preoperative dose has been found to be enough o
significantly reduce dental implant failures compared to no antibiotic or placebo.
Even so, the most recent cross-sectional studies reveal an antibiotic over prescription
in relation to this type of surgical procedures, being very common in some countries, such
as Spain and Italy, the prescription of antibiotic from one or two days before implant
placement to five or seven days after surgery [9,10].
The results obtained gree with those found in recent systematic reviews and meta-
analyzes [30–33]. Canullo et al. concluded that antibiotic prophylaxis prevents early
implant failures in healthy patients [31]. Romandini et al. determined that antibiotic
prophylaxis is necessary in implant placement procedures but that there is insufficient
evidence to recommend a specific dosage [30]. They also concluded that the prescription
of postoperative antibiotics is not justified [30]. Finally, Kim et al. affirmed that the
administration of antibiotic prophylaxis reduces the risk of early implant failure but further
research is necessary to stablish a standardized protocol [32].
It should be taken into account that the included RCTs treated patients without
systemic conditions that could pose a greater risk of implant failure, so if the protective
effect of the antibiotic is observed in healthy patients, its use is indisputable in patients
at risk.
All the studies that focused on the effect of antibiotic regimens in early implant failure
used amoxicillin as the antibiotic of choice or, in case of allergy, clindamycin. However,
it appears that bacteria genes encoding resistance to metronidazole are less frequent in
peri-implant tissues than those that encode resistance to beta-lactams [34]. In addition,
bacteria related to dental implant failure [35] and peri-implantitis [36,37] can be variable
and complex, but it consists in part of Gram-negative anaerobic species against which
metronidazole is the antibiotic of choice [38,39]. For these reasons, it would be interesting
to investigate the effectiveness of metronidazole in reducing dental implant failure.
On the other hand, local antibacterial drug delivery systems are being investigated
in the field of oral implantology, which would allow to maintain the minimum inhibitory
concentration of antibiotic around dental implants during the osseointegration time [40,41].
Although the mechanisms of antibiotic therapy in implant dentistry could change a
lot in the coming decades, due to the large number of dental implants placed each year
and therefore the large number of patients undergoing antibiotic prophylaxis, it is essential
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to establish antibiotic protocols both for patients at risk and for healthy patients. It would
also be interesting to differentiate between simple and complex implant procedures.
The limitations of the present study are the small sample and the unclear risk of bias
especially regarding the blinding of participants and researchers in some of the included
studies, the low number of RCTs with a follow-up period of at least 3 months that analyze
this question and the lack of studies comparing different doses of preoperative amoxicillin
prophylaxis.
5. Conclusions
Systemic antibiotic prophylaxis significantly reduces early dental implant failures in
healthy patients. There is no statistically significant difference in the occurrence of this
event when comparing the pre and postoperative administration of systemic antibiotics
with the prescription of a single preoperative antibiotic dose. Therefore, the continuation
of antibiotic treatment postoperatively would not be indicated in these patients.
Future research should be aimed at establishing differences between the systemic
antibiotic needs of healthy patients versus patients with systemic diseases, of patients with
or without different types of oral diseases or comparing simple implant surgeries versus
complex procedures. In addition, RCTs comparing different single preoperative antibiotic
doses should be performed.
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